| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 1407-1421, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
RA Clark, MG Tonnesen, J Gailit and DA Cheresh
Department of Dermatology, State University of New York at Stony Brook, 11794-8165, USA.
During early granulation tissue formation of wound repair, new capillaries invade the fibrin clot, a process that undoubtedly requires an interaction of vascular cells with the wound provisional matrix composed mainly of fibrin, fibronectin, and vitronectin. Integrin alphaVbeta3 is the vascular cell receptor for these wound-associated adhesive proteins. Therefore, we investigated the expression of this receptor on new capillaries of healing full-thickness cutaneous porcine wounds. During granulation tissue formation, alphaVbeta3 was expressed specifically on capillary sprouts invading the central fibrin clot whereas the closely related integrin alphaVbeta5 failed to localize to these cells. Cyclic peptides or antibody antagonists of alphaVbeta3 specifically inhibited granulation tissue formation in a transient manner during the period of invasive angiogenesis. Immunolocalization studies revealed that alphaVbeta3 became aggregated and lost from sprouting vessels after treatment with a peptide antagonist. In contrast, beta 1 integrins were not modulated by this treatment. Once granulation tissue filled the wound and invasive angiogenesis terminated, the alphaVbeta3 showed little or no expression in the granulation tissue microvasculature. These data demonstrate that integrin alphaVbeta3 plays a fundamental, but transient, role during invasive angiogenesis and granulation tissue formation in a healing wound.
This article has been cited by other articles:
 |
|
 |
|
  Y. Fu, M. L. Ponce, M. Thill, P. Yuan, N. S. Wang, and K. G. Csaky Angiogenesis Inhibition and Choroidal Neovascularization Suppression by Sustained Delivery of an Integrin Antagonist, EMD478761 Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5184 - 5190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Frame, R. J. Rivers, O. Altland, and S. Cameron Mechanisms initiating integrin-stimulated flow recruitment in arteriolar networks J Appl Physiol, June 1, 2007; 102(6): 2279 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Nisato, G. Hosseini, C. Sirrenberg, G. S. Butler, T. Crabbe, A. J.P. Docherty, M. Wiesner, G. Murphy, C. M. Overall, S. L. Goodman, et al. Dissecting the Role of Matrix Metalloproteinases (MMP) and Integrin {alpha}v{beta}3 in Angiogenesis In vitro: Absence of Hemopexin C Domain Bioactivity, but Membrane-Type 1-MMP and {alpha}v{beta}3 Are Critical Cancer Res., October 15, 2005; 65(20): 9377 - 9387. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. K. Scaffidi, N. Petrovic, Y. P. Moodley, M. Fogel-Petrovic, K. M. Kroeger, R. M. Seeber, K. A. Eidne, P. J. Thompson, and D. A. Knight {alpha}v{beta}3 Integrin Interacts with the Transforming Growth Factor {beta} (TGF{beta}) Type II Receptor to Potentiate the Proliferative Effects of TGF{beta}1 in Living Human Lung Fibroblasts J. Biol. Chem., September 3, 2004; 279(36): 37726 - 37733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. J. Boudreau and J. A. Varner The Homeobox Transcription Factor Hox D3 Promotes Integrin {alpha}5{beta}1 Expression and Function during Angiogenesis J. Biol. Chem., February 6, 2004; 279(6): 4862 - 4868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Hiran, J. E. Mazurkiewicz, P. Kreienberg, F. L. Rice, and S. E. LaFlamme Endothelial expression of the {alpha}6{beta}4 integrin is negatively regulated during angiogenesis J. Cell Sci., September 15, 2003; 116(18): 3771 - 3781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. HIRSCHI, T. C. SKALAK, S. M. PEIRCE, and C. D. LITTLE Vascular Assembly in Natural and Engineered Tissues Ann. N.Y. Acad. Sci., June 1, 2002; 961(1): 223 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Zhang, C. Li, and P. C. Baciu Expression of Integrins and MMPs during Alkaline-Burn-Induced Corneal Angiogenesis Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 955 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ren, L. H. Michael, M. L. Entman, and N. G. Frangogiannis Morphological Characteristics of the Microvasculature in Healing Myocardial Infarcts J. Histochem. Cytochem., January 1, 2002; 50(1): 71 - 80. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. C.Y. Chan, D. A. Duszczyszyn, F. J. Castellino, and V. A. Ploplis Accelerated Skin Wound Healing in Plasminogen Activator Inhibitor-1-Deficient Mice Am. J. Pathol., November 1, 2001; 159(5): 1681 - 1688. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kamizuru, H. Kimura, T. Yasukawa, Y. Tabata, Y. Honda, and Y. Ogura Monoclonal Antibody-Mediated Drug Targeting to Choroidal Neovascularization in the Rat Invest. Ophthalmol. Vis. Sci., October 1, 2001; 42(11): 2664 - 2672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. F. Retta, G. Cassara, M. D'Amato, R. Alessandro, M. Pellegrino, S. Degani, G. De Leo, L. Silengo, and G. Tarone Cross Talk between beta 1 and alpha V Integrins: beta 1 Affects beta 3 mRNA Stability Mol. Biol. Cell, October 1, 2001; 12(10): 3126 - 3138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A.F. CLARK Fibrin and Wound Healing Ann. N.Y. Acad. Sci., June 1, 2001; 936(1): 355 - 367. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Collen, A. Maas, T. Kooistra, F. Lupu, J. Grimbergen, F. J. L. M. Haas, D. H. Biesma, P. Koolwijk, J. Koopman, and V. W. M. van Hinsbergh Aberrant fibrin formation and cross-linking of fibrinogen Nieuwegein, a variant with a shortened A{alpha}-chain, alters endothelial capillary tube formation Blood, February 15, 2001; 97(4): 973 - 980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Cirulli, G. M. Beattie, G. Klier, M. Ellisman, C. Ricordi, V. Quaranta, F. Frasier, J. K. Ishii, A. Hayek, and D. R. Salomon Expression and Function of {alpha}v{beta}3 and {alpha}v{beta}5 Integrins in the Developing Pancreas: Roles in the Adhesion and Migration of Putative Endocrine Progenitor Cells J. Cell Biol., September 18, 2000; 150(6): 1445 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. P. Kohler and P. J. Grant Plasminogen-Activator Inhibitor Type 1 and Coronary Artery Disease N. Engl. J. Med., June 15, 2000; 342(24): 1792 - 1801. [Full Text] [PDF]
|
|
|
|
|
|
G. E. Davis, K. J. Bayless, M. J. Davis, and G. A. Meininger Regulation of Tissue Injury Responses by the Exposure of Matricryptic Sites within Extracellular Matrix Molecules Am. J. Pathol., May 1, 2000; 156(5): 1489 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Paavonen, P. Puolakkainen, L. Jussila, T. Jahkola, and K. Alitalo Vascular Endothelial Growth Factor Receptor-3 in Lymphangiogenesis in Wound Healing Am. J. Pathol., May 1, 2000; 156(5): 1499 - 1504. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kim, K. Bell, S. A. Mousa, and J. A. Varner Regulation of Angiogenesis in Vivo by Ligation of Integrin {alpha}5{beta}1 with the Central Cell-Binding Domain of Fibronectin Am. J. Pathol., April 1, 2000; 156(4): 1345 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Leng, R. L. Klemke, A. C. Reddy, and D. A. Cheresh Potentiation of Cell Migration by Adhesion-dependent Cooperative Signals from the GTPase Rac and Raf Kinase J. Biol. Chem., December 31, 1999; 274(53): 37855 - 37861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Collo and M. Pepper Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro J. Cell Sci., January 2, 1999; 112(4): 569 - 578. [Abstract] [PDF]
|
|
|
|
 |
|
 S. H. Tam, P. M. Sassoli, R. E. Jordan, and M. T. Nakada Abciximab (ReoPro, Chimeric 7E3 Fab) Demonstrates Equivalent Affinity and Functional Blockade of Glycoprotein IIb/IIIa and {alpha}vß3 Integrins Circulation, September 15, 1998; 98(11): 1085 - 1091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Eliceiri, R. Klemke, S. Stromblad, and D. A. Cheresh Integrin alpha vbeta 3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis J. Cell Biol., March 9, 1998; 140(5): 1255 - 1263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Klemke, J. Leng, R. Molander, P. C. Brooks, K. Vuori, and D. A. Cheresh CAS/Crk Coupling Serves as a "Molecular Switch" for Induction of Cell Migration J. Cell Biol., February 23, 1998; 140(4): 961 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.S. Srivatsa, L. A Fitzpatrick, P. W Tsao, T. M Reilly, D. R Holmes Jr, R. S Schwartz, and S. A Mousa Selective {alpha}v{beta}3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury:: Evidence for the functional importance of integrin {alpha}v{beta}3 and osteopontin expression during neointima formation Cardiovasc Res, December 1, 1997; 36(3): 408 - 428. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Klemke, S. Cai, A. L. Giannini, P. J. Gallagher, P. d. Lanerolle, and D. A. Cheresh Regulation of Cell Motility by Mitogen-activated Protein Kinase J. Cell Biol., April 21, 1997; 137(2): 481 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Pepper Manipulating Angiogenesis: From Basic Science to the Bedside Arterioscler. Thromb. Vasc. Biol., April 1, 1997; 17(4): 605 - 619. [Abstract] [Full Text]
|
|
|
|
|
|
D Greiling and R. Clark Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix J. Cell Sci., January 4, 1997; 110(7): 861 - 870. [Abstract] [PDF]
|
|
|
|
|
|
K. Yokoyama, H. P. Erickson, Y. Ikeda, and Y. Takada Identification of Amino Acid Sequences in Fibrinogen gamma -Chain and Tenascin C C-terminal Domains Critical for Binding to Integrin alpha vbeta 3 J. Biol. Chem., May 26, 2000; 275(22): 16891 - 16898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Grzeszkiewicz, D. J. Kirschling, N. Chen, and L. F. Lau CYR61 Stimulates Human Skin Fibroblast Migration through Integrin alpha vbeta 5 and Enhances Mitogenesis through Integrin alpha vbeta 3, Independent of Its Carboxyl-terminal Domain J. Biol. Chem., June 8, 2001; 276(24): 21943 - 21950. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Papetti and I. M. Herman Mechanisms of normal and tumor-derived angiogenesis Am J Physiol Cell Physiol, May 1, 2002; 282(5): C947 - C970. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
